Clinical Trials Directory

Trials / Completed

CompletedNCT04430439

Emotion-Diet Interactions in Pregnancy

Postprandial Response to Emotion-Diet Interactions in Pregnancy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study will investigate how maternal emotional state following a controlled stress exposure in pregnancy influences blood glucose and insulin levels after eating a standardized meal, and whether the effects of emotional state on blood glucose and insulin is different after eating a healthy meal (low GI) compared to a less healthy meal (high GI).

Detailed description

Maternal glucose-insulin homeostasis in pregnancy represents one of the most important physiological processes for maternal and child health outcomes. Although maternal diet is a key regulator of this process, its effects vary widely across individuals. Maternal stress could represent a moderator of considerable importance in this regard, yet little is known about the effects of stress on glycemic control in pregnancy and whether the effects of stress may vary as a function of diet quality. This project will investigate the effects of acute psychosocial stress exposure on the postprandial metabolic response to a meal of varying glycemic index (GI) among women with overweight/obesity in mid-pregnancy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychosocial stressThe TSST is a 15 minute standardized lab-based challenge task that involves speech preparation, speech delivery while being evaluated by strangers and video taped, and complex mental arithmetic with critiques if errors are made.
BEHAVIORALControl non-stressParticipants will have a relaxed 15 minute conversation with a familiar research team member.

Timeline

Start date
2021-05-11
Primary completion
2024-02-14
Completion
2024-02-28
First posted
2020-06-12
Last updated
2025-08-22
Results posted
2025-08-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04430439. Inclusion in this directory is not an endorsement.